Psyched Wellness Ltd.

Psyched Wellness Ltd.

PSYC.CN
Psyched Wellness Ltd.CA flagCanadian Securities Exchange
0.01
CAD
- -
- -
3.14MMarket Cap
Psyched Wellness Ltd.
PSYC.CN
(Canadian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.01
- -
- -
- -
- -
-0.01
-0.02
-0.08
-0.09
-0.03
-0.04
-0.03
-0.02
-0.02
-0.02
-0.02
Basic EPS, GAAP
-0.01
-0.02
-0.01
- -
- -
- -
- -
- -
-0.04
-0.02
-0.04
-0.02
-0.02
-0.02
-0.01
-0.01
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.13
-0.1
-0.09
-0.08
-0.07
-0.07
0.01
-0.01
-0.37
-0.2
0.03
0.01
-0.02
-0.01
- -
-0.01
-0.02
Book Value per Share
0.01
0.03
0.03
0.03
0.02
0.02
0.02
- -
-0.25
-0.1
0.04
0.05
0.02
0.04
0.03
0.01
0.01
Tangible Book Value per Share
64
82
96
106
125
126
126
126
3
4
61
125
135
162
237
289
289
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
Sales/Revenue/Turnover
56,926.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-28,586.49
-1,036.86
-728.73
-1,076.95
-865.66
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
-1
-2
- -
- -
-2
-4
-4
-3
-4
-5
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
57,058.79
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-30,093.91
-1,069.26
-683.58
-1,066.18
-882.36
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
-1
-1
- -
3
6
3
7
7
3
2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1
2
3
3
3
3
2
-1
-1
- -
3
6
3
7
7
3
2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-301.06
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Aug'25
Nov'25
Feb'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
289
289
289
Market Capitalization
6
4
3

Working Capital

FRC

in mil. unless spec.
Aug'25
Nov'25
Feb'26
Total Current Assets
5
4
2
Cash, Cash Equivalents & STI
3
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
1
Total Current Liabilities
- -
1
- -
Payables & Accruals
- -
1
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-89.9%
23.8%
-58.25%
Free Cash Flow
325.62%
12.86%
30.44%
Net Income, GAAP
124.16%
26.94%
18.21%
Sales/Revenue/Turnover
- -
- -
-24.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
-0.01
- -
-0.02
2025
- -
-0.01
- -
- -
-0.02
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Psyched Wellness Ltd. is a Canada-based health supplements company focused on the production and distribution of mushroom-derived consumer packaged goods, primarily from Amanita muscaria utilizing its proprietary AME-1 water-based extract; core products include Calm (available in 30 ml and 60 ml formats as liquid extracts for stress relief, relaxation, and restful sleep), the recently launched Calmer (a higher-potency 2x version of Calm with enhanced flavor profile introduced in November 2025), and Santa (a new dietary supplement shot with initial production completed in September 2025 ahead of a soft launch and holiday season expansion). Founded in 1981 as Duncan Park Holdings Corporation and renamed Psyched Wellness Ltd. in July 2020, the company is headquartered at 36 Toronto Street, Toronto, Ontario, with registered offices at 77 King Street West, Suite 3000, and operates primarily in North America through direct-to-consumer online sales via its e-commerce platform launched in 2025, targeting the functional food and wellness sectors with products aimed at mood support and body restoration. Recent developments encompass a US$7.5 million non-brokered private placement finalized in May 2024 with Gotham Green Partners including strategic advisory partnerships, a USPTO patent application for scaled-up extraction process filed August 2025 (pending in the US and Canada), completion of genotoxicity studies and stability testing extending Calm's shelf life to 18 months announced in April 2025, a voluntary New Dietary Ingredient Notification to the FDA in July 2025 for AME-1 despite subsequent non-concurrence, board changes with a new director appointment and resignation in November 2024, and ongoing route-to-market partnership expansions for distribution.